Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reda Rawi

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Nature Microbiology|November 1, 2025
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein BRyan S Roark, Andrew J Schaub, Wei Shi, et al.
The Journal of Experimental Medicine|June 23, 2022
Highly protective antimalarial antibodies via precision library generation and yeast display screeningBailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Iscience|July 18, 2025
<i>In silico</i> improvement of affinity for highly protective anti-malarial antibodiesMateo Reveiz, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Nature Microbiology|April 10, 2025
A broadly protective human antibody for GI genogroup norovirusesInga Rimkute, Adam S Olia, Mehin Suleiman, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 23, 2022
Development of Neutralization Breadth against Diverse HIV-1 by Increasing Ab-Ag Interface on V2Nan Gao, Yanxin Gai, Lina Meng, et al.
Immunity|November 10, 2022
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A virusesSyed M Moin, Jeffrey C Boyington, Seyhan Boyoglu-Barnum, et al.
Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.
Cell Reports|December 15, 2024
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodiesEvan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.
Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.
Cell Reports|February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing AntibodyYoung D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Nature Microbiology|November 1, 2025
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein BRyan S Roark, Andrew J Schaub, Wei Shi, et al.
The Journal of Experimental Medicine|June 23, 2022
Highly protective antimalarial antibodies via precision library generation and yeast display screeningBailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Iscience|July 18, 2025
<i>In silico</i> improvement of affinity for highly protective anti-malarial antibodiesMateo Reveiz, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Nature Microbiology|April 10, 2025
A broadly protective human antibody for GI genogroup norovirusesInga Rimkute, Adam S Olia, Mehin Suleiman, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 23, 2022
Development of Neutralization Breadth against Diverse HIV-1 by Increasing Ab-Ag Interface on V2Nan Gao, Yanxin Gai, Lina Meng, et al.
Immunity|November 10, 2022
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A virusesSyed M Moin, Jeffrey C Boyington, Seyhan Boyoglu-Barnum, et al.
Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.
Cell Reports|December 15, 2024
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodiesEvan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.
Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.
Cell Reports|February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing AntibodyYoung D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.
Pageof 9